The artificial intelligence (AI) system could initially reduce the number of unnecessary biopsies, a significant health-care cost.

TOP INSIGHT
If melanoma is recognized and treated early, it is almost always curable, but if it is not, the cancer can advance and spread to other parts of the body, where it becomes hard to treat and can be fatal.
The AI system--trained using tens of thousands of skin images and their corresponding eumelanin and hemoglobin levels--could initially reduce the number of unnecessary biopsies, a significant health-care cost. It gives doctors objective information on lesion characteristics to help them rule out melanoma before taking more invasive action.
The technology could be available to doctors as early as next year.
"This could be a very powerful tool for skin cancer clinical decision support," said Alexander Wong, a professor of systems design engineering at Waterloo. "The more interpretable information there is, the better the decisions are."
Currently, dermatologists largely rely on subjective visual examinations of skin lesions such as moles to decide if patients should undergo biopsies to diagnose the disease.
"There can be a huge lag time before doctors even figure out what is going on with the patient," said Wong who is also the Canada Research Chair in Medical Imaging Systems. "Our goal is to shorten that process."
The research was recently presented at the 14th International Conference on Image Analysis and Recognition in Montreal.
Source-Eurekalert
MEDINDIA



Email










